| # | Side effect | Count |
|---|---|---|
| 0 | HEPATIC FUNCTION ABNORMAL | 22 |
| 1 | INTERSTITIAL LUNG DISEASE | 22 |
| 2 | OSTEONECROSIS OF JAW | 19 |
| 3 | WHITE BLOOD CELL COUNT DECREASED | 18 |
| 4 | MALIGNANT NEOPLASM PROGRESSION | 16 |
| 5 | OSTEOMYELITIS | 16 |
| 6 | FATIGUE | 15 |
| 7 | ANAEMIA | 12 |
| 8 | ASPARTATE AMINOTRANSFERASE INCREASED | 12 |
| 9 | OEDEMA PERIPHERAL | 12 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | JAW LESION EXCISION | 1 | 0.0909 |
| 1 | LUNG CYST BENIGN | 1 | 0.0909 |
| 2 | REEXPANSION PULMONARY OEDEMA | 1 | 0.0833 |
| 3 | SINUS POLYP DEGENERATION | 2 | 0.0690 |
| 4 | ENDOMETRIAL STROMAL SARCOMA | 2 | 0.0400 |
| 5 | ENDOMETRIAL DYSPLASIA | 1 | 0.0400 |
| 6 | SECONDARY SEQUESTRUM | 1 | 0.0357 |
| 7 | ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA | 1 | 0.0357 |
| 8 | ENDOMETRIAL HYPERTROPHY | 11 | 0.0276 |
| 9 | ENDOMETRIAL CANCER STAGE III | 2 | 0.0253 |